News
Marksans Pharma completes of Netherlands-based QliniQ B.V.
16-Jun-2026 | 18:56
Marksans Pharma has completed the acquisition of 100% share capital of QliniQ B.V. based in the Netherlands.
Marksans Pharma has completed the acquisition of 100% share capital of QliniQ B.V. based in the Netherlands.